Improvement in MASH with no worsening of fibrosis occurred in 47% of the participants in the survodutide 2.4 mg group, 62% of those in the 4.8 mg group, and 43% of those in the 6.0 mg group, as ...

Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from ...

Text-to-image AI art generators are cutting-edge tools that use artificial intelligence (AI) to turn written descriptions into visual art. At the heart of these generators is a complex process where ...